Kawa KS

Language: Spanish
References: 10
Page: 115-117
PDF size: 68.73 Kb.

Text Extraction

No abstract

REFERENCES

1. Schwartz LM, Smith SW, Jones MEE, Osborne BA. Do all program cell deaths occur via apoptosis? Proc Natl Acad Sci USA 1993; 90: 980-4.

2. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death immunity. Annu Rev lmmunol 1992; 10: 267-93.

3. Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 1993; 14: 133-51.

4. Askew DS, Ashun RA, Simmons BC, Cleveland JL Constitutive c-myc expression in IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991; 6: 1915-1922

5. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Pen LZ, Hancock DC lnduction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.

6. Clotta F, Polentarutti N, Sironi M, Mantovani A. Expression and involvement of c-fos and c-jun protooncogens in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 1992; 267: 18278-18283

7. Smeyne RJ, Vendrell M, Hayward M, Baker SJ. Miao GG. Schilliwn K, Robertson IM, Curran T, Morgan JI. Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993; 363: 1166-169

8. Bissonnette RP, Echeverri F, Mahboubi A, Green DS. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359: 552-554

9. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgenindependent prostate cancer. Cancer Res 1992; 52: 694-6944

10. 10.Rotello RJ, Leiberman RC, Lepoff RB, Gerschenson LE. Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486. Am J Pathol 1992; 140: 449-456.